Skip to main content
Fig. 4 | BMC Rheumatology

Fig. 4

From: Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis

Fig. 4

Correlation between serum levels of ROM at 12 weeks and DAS28-ESR at 52 weeks. Serum levels of ROM at 12 weeks are well correlated with DAS28-ESR at 52 weeks (r = 0.597, p < 0.01). ROM: reactive oxygen metabolites; DAS: disease activity score; ESR: erythrocyte sedimentation rate

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us